Multiple myloma (MM) is a cancer of plasma cells and is on the rise worldwide, particularly in the US, Australia, and Western Europe. Nearly 2% of cancer diagnoses and more than 2% of cancer deaths in
Colorectal cancer (CRC) is a leading cause of cancer-related deaths. Because of the lack of reliable prognostic and predictive biomarkers for CRC, most patients are often diagnosed at a late stage. Th
* Difference was considered significant at P < 0.05. Logistic regression analysis showing the association of miR-122, miR-221 and miR-21 with drug responsiveness among HCV-4 patients.
